This text investigates the methodologies and practical applications of structure-based drug design in the development of novel pharmaceutical compounds. Pandi Veerapandian, an expert in computational chemistry and structural biology, synthesizes complex data regarding protein-ligand interactions and molecular modeling. The book provides a comprehensive framework for researchers to utilize structural information to optimize drug efficacy and minimize toxicity in clinical candidates.

Experts recognize this work as a foundational technical reference for medicinal chemists and structural biologists. Readers frequently note the high level of academic density and the rigorous focus on computational modeling techniques.